Sibel Blau
AuthID: R-00K-V95
1
TÃTULO: XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease
AUTORES: Schmid, Peter; Cortes, Javier; Joaquim, Ana; Janez, Noelia Martinez; Morales, Serafin; Diaz Redondo, Tamara; Blau, Sibel; Neven, Patrick; Lemieux, Julie; Garcia Saenz, Jose Angel; Hart, Lowell; Biyukov, Tsvetan; Baktash, Navid; Massey, Dan; Burris, Howard A., III; Rugo, Hope S.;
PUBLICAÇÃO: 2023, FONTE: BREAST CANCER RESEARCH, VOLUME: 25, NÚMERO: 1
AUTORES: Schmid, Peter; Cortes, Javier; Joaquim, Ana; Janez, Noelia Martinez; Morales, Serafin; Diaz Redondo, Tamara; Blau, Sibel; Neven, Patrick; Lemieux, Julie; Garcia Saenz, Jose Angel; Hart, Lowell; Biyukov, Tsvetan; Baktash, Navid; Massey, Dan; Burris, Howard A., III; Rugo, Hope S.;
PUBLICAÇÃO: 2023, FONTE: BREAST CANCER RESEARCH, VOLUME: 25, NÚMERO: 1
INDEXADO EM: 
Scopus 
WOS
Scopus WOS